Genomic Variations and Immune-Related Features of TMB, PD-L1 Expression and CD8+ T Cell Infiltration in Chinese Pulmonary Sarcomatoid Carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Genomic Variations and Immune-Related Features of TMB, PD-L1 Expression and CD8+ T Cell Infiltration in Chinese Pulmonary Sarcomatoid Carcinoma

Published:2022-04 Issue: Volume:Volume 15 Page:4209-4220
ISSN:1178-7074
Container-title:International Journal of General Medicine
language:en
Short-container-title:IJGM

Author:

Zhang Chenyue,Li Zhenxiang^ORCID,Zhang Yanxiang,Zhao Chenglong,Wang Hui^ORCID,Lin Jiamao,Liu Cuicui,Wang Xiaohui,Wang Haiyong^ORCID

Publisher

Informa UK Limited

Subject

General Medicine

Reference40 articles.

1. Outcomes of sarcomatoid carcinoma of the lung: A Surveillance, Epidemiology, and End Results database analysis

2. Efficacy of First-Line Chemotherapy in Patients with Advanced Lung Sarcomatoid Carcinoma

3. Next-Generation Sequencing of Pulmonary Sarcomatoid Carcinoma Reveals High Frequency of Actionable MET Gene Mutations

4. Characteristics and Clinical Outcomes of Sarcomatoid Carcinoma of the Lung

5. EGFR and KRAS status of primary sarcomatoid carcinomas of the lung: Implications for anti-EGFR treatment of a rare lung malignancy

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. USP9X inhibits metastasis in pulmonary sarcomatoid carcinoma by regulating epithelial-mesenchymal transition, angiogenesis and immune infiltration;Translational Oncology;2024-09

2. Obesity-Dependent Association of the rs10454142 PPP1R21 with Breast Cancer;Biomedicines;2024-04-08

3. Biological characteristics and clinical treatment of pulmonary sarcomatoid carcinoma: a narrative review;Translational Lung Cancer Research;2024-03

4. Role of immunotherapy in pulmonary sarcomatoid carcinoma: review of current approaches and related biomarkers;Therapeutic Advances in Medical Oncology;2024-01

5. Targeted therapy for rare lung cancers: Status, challenges, and prospects;Molecular Therapy;2023-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3